Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",51253,2798,0.83 [0.76-0.91],5.885289854984595e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Candidiasis,51825,861,0.74 [0.63-0.87],0.0002907803635868
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,50260,7080,0.84 [0.80-0.89],4.211100721686628e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50452,6456,0.86 [0.81-0.91],4.872122299250641e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51314,2455,0.88 [0.80-0.96],0.0063683696979115
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,46072,2229,0.78 [0.71-0.87],2.0610188721075915e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45817,517,0.73 [0.60-0.90],0.0033115097820364
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36416,4000,0.83 [0.77-0.90],1.6552939206426136e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45512,789,0.67 [0.57-0.79],3.019467498014485e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51752,2893,0.86 [0.79-0.94],0.001018157748279
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Mycoses,51983,1019,0.75 [0.65-0.87],0.0001385615651426
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50333,1878,0.80 [0.72-0.90],7.97961794863101e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,49015,560,0.65 [0.53-0.79],1.953252633996754e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51954,304,0.59 [0.46-0.77],0.0001161795572707
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter I Certain infectious and parasitic diseases,Viral warts,51749,99,0.49 [0.31-0.78],0.002263962244298
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,Lung cancer and mesothelioma,36120,664,0.55 [0.47-0.65],2.0279049148173488e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41836,452,0.65 [0.53-0.81],8.965006433221266e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50476,5839,0.86 [0.81-0.92],4.1503584316483645e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,51100,3061,0.83 [0.76-0.90],1.232387816376903e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,51098,3059,0.83 [0.76-0.90],1.3986388637565482e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51422,2405,0.82 [0.74-0.90],4.366020835158841e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51872,110,2.11 [1.35-3.30],0.0010661644696027
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40307,640,0.68 [0.56-0.81],3.6689453950053234e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39778,111,0.39 [0.26-0.60],1.0404520278057957e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",51134,1144,0.83 [0.72-0.95],0.0083285181957194
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45377,3051,0.89 [0.82-0.97],0.0065963721991962
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,40232,565,0.68 [0.56-0.83],0.0001703027465589
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46794,7127,0.79 [0.75-0.83],1.8996586189173087e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,40057,390,0.57 [0.45-0.73],3.716331123370544e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40784,1117,0.72 [0.63-0.83],7.0823755079349485e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51919,658,0.74 [0.61-0.88],0.0009668908223118
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39924,257,0.63 [0.47-0.85],0.0023243692243726
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40946,1279,0.74 [0.65-0.85],9.925176024342443e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39907,240,0.62 [0.46-0.84],0.0021290016845545
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40879,1212,0.56 [0.49-0.64],1.6864030002494566e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40636,969,0.68 [0.58-0.79],4.27741332225055e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46875,142,0.54 [0.37-0.80],0.0018300572852312
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49705,10038,0.79 [0.75-0.83],5.101291660030655e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51706,3934,0.84 [0.78-0.90],5.414151845486162e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51709,3930,0.84 [0.78-0.90],5.033355177950968e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51389,2433,0.88 [0.80-0.97],0.0073474127174773
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42850,3183,0.67 [0.62-0.73],4.097112918127964e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,52059,456,0.71 [0.57-0.89],0.0024953137962483
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50792,3709,0.62 [0.57-0.67],4.1334300523953166e-34
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,41216,1549,0.68 [0.60-0.76],1.666994668661074e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49809,328,0.66 [0.51-0.86],0.0017560527591876
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Angina pectoris,47572,2405,0.82 [0.74-0.90],6.91242734180978e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32310,3852,0.90 [0.83-0.97],0.0085491555171293
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49325,4194,0.85 [0.79-0.91],9.435070950279226e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45455,15262,0.83 [0.80-0.87],2.1790860241442206e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertension,47299,13099,0.79 [0.76-0.83],6.705343310105271e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47336,13136,0.79 [0.76-0.83],7.984178859170866e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34553,353,0.66 [0.51-0.85],0.0011040336137504
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34477,277,0.59 [0.44-0.78],0.000245479667719
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Hypotension,51792,2376,0.79 [0.72-0.87],2.873168461285564e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49664,4497,0.86 [0.80-0.92],1.742515607330656e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51324,1126,0.79 [0.69-0.91],0.001275930505715
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,51120,1691,0.82 [0.73-0.92],0.0005845228198268
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46595,1428,0.83 [0.73-0.94],0.0032463512008327
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",52026,621,0.73 [0.60-0.88],0.0008424126864278
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49961,480,0.70 [0.56-0.86],0.0008564830304165
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,49196,131,0.55 [0.36-0.82],0.003478053213043
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50302,1237,0.73 [0.64-0.84],6.333426829637728e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51301,1288,0.80 [0.70-0.92],0.001098859640464
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",51259,1365,0.82 [0.72-0.93],0.0027060983129268
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50673,475,0.69 [0.56-0.85],0.000656552345222
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49952,523,0.71 [0.58-0.87],0.0012165765305186
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter IX Diseases of the circulatory system,Varicose veins,49622,853,1.25 [1.06-1.48],0.0071245796485696
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45560,2874,0.86 [0.79-0.94],0.0011094942986042
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Any mental disorder,50761,8075,0.85 [0.81-0.90],8.72790257784469e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45890,3204,0.89 [0.82-0.97],0.0082425165224023
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,Smoking dependency,51013,2765,0.70 [0.64-0.76],1.5593244795164404e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45978,3292,0.77 [0.72-0.84],2.140548602340605e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,52050,120,0.46 [0.31-0.69],0.000215315060473
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,51110,2770,0.85 [0.78-0.94],0.0006521182326323
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50878,5196,0.89 [0.83-0.95],0.0004018496915461
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50732,2418,0.86 [0.78-0.94],0.0014701776564421
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Neurological diseases,49090,7603,0.85 [0.81-0.90],8.822575166406004e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",49146,832,0.74 [0.63-0.87],0.0003022871959374
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41414,1301,0.78 [0.68-0.89],0.000214828181533
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other disorders of nervous system,51079,281,0.61 [0.46-0.81],0.000483378606572
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other neurological diseases,51841,1043,0.77 [0.67-0.89],0.000430836026122
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VI Diseases of the nervous system,Other sleep disorders,49470,1130,0.82 [0.71-0.94],0.0045918206834255
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51734,468,0.71 [0.57-0.88],0.0018789758294889
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5120,204,1.79 [1.30-2.48],0.0003623997280544
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51811,550,0.74 [0.61-0.91],0.0035839524804274
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51757,222,0.66 [0.48-0.90],0.0084130623377347
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48860,4376,0.86 [0.80-0.92],3.481299926948956e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,48111,3627,0.83 [0.77-0.90],4.2827157421069525e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51887,1815,0.83 [0.74-0.93],0.0010027235994021
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,50246,174,0.59 [0.41-0.84],0.0030303421488457
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38479,3568,0.80 [0.74-0.87],4.972154495970335e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38970,3514,0.80 [0.73-0.86],3.222670915513574e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47939,164,0.60 [0.42-0.86],0.0056393927073406
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Bronchiectasis,45142,708,0.68 [0.57-0.81],2.19797919742784e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,50044,5610,0.78 [0.73-0.83],2.5146213632165736e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51680,2394,0.70 [0.64-0.77],5.885045317060177e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47926,10602,0.85 [0.81-0.89],2.866795294864256e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49909,731,0.76 [0.64-0.91],0.0022883466621273
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Early onset COPD,49921,635,0.58 [0.49-0.69],7.372630568289721e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Emphysema,45067,633,0.59 [0.49-0.71],6.862849026603049e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49473,578,0.49 [0.40-0.59],1.482255041046292e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51636,3861,0.77 [0.71-0.83],1.623953803097751e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Interstitial lung disease,49542,647,0.52 [0.43-0.62],8.964481627015953e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Later onset COPD,50068,1759,0.74 [0.67-0.83],1.591926726555213e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51581,1954,0.82 [0.74-0.92],0.0004194916680554
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other diseases of pleura,51607,4004,0.83 [0.77-0.89],7.063625691038743e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51907,807,0.59 [0.50-0.70],3.1351015806004224e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51868,2607,0.80 [0.73-0.87],1.2927044741748944e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Pleural effusion,49605,2002,0.87 [0.78-0.96],0.0087714249335184
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",51128,3353,0.76 [0.71-0.83],1.0248573321269551e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51538,1911,0.82 [0.73-0.91],0.0002544190419767
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Viral pneumonia,48278,503,0.68 [0.55-0.83],0.00025261236538
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51293,414,0.68 [0.54-0.86],0.0010250894733248
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,24025,225,0.65 [0.47-0.89],0.0076662344686674
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Barrett oesophagus,39879,879,0.81 [0.69-0.95],0.0089059698153607
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Constipation,51565,3376,0.82 [0.75-0.89],1.2497446141441734e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn disease,48722,187,0.48 [0.34-0.67],1.2716644255390806e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48711,176,0.48 [0.34-0.67],1.8468631725872663e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Dental caries,50586,461,0.67 [0.54-0.83],0.0002604088297441
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46736,4476,0.86 [0.80-0.92],2.631498071853612e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47715,8715,0.90 [0.86-0.95],7.047958188786081e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,43007,6351,0.84 [0.79-0.89],4.717942385482825e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Functional dyspepsia,40106,1106,0.82 [0.71-0.95],0.0064827521211263
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastric ulcer,39722,722,0.76 [0.64-0.91],0.002635725690066
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,44046,5046,0.87 [0.81-0.93],6.166612579192436e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,40081,1081,0.77 [0.66-0.88],0.0002893951576355
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40324,16717,0.93 [0.90-0.97],0.0002473624066576
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Hernia,48791,6531,0.89 [0.84-0.94],7.632210428566691e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37768,1112,0.76 [0.66-0.88],0.0002129488321726
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,52026,747,0.77 [0.65-0.91],0.0023792561206056
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48557,566,0.70 [0.58-0.85],0.0004075823649129
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestine,40168,3512,0.83 [0.77-0.90],6.118759064526948e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of intestines,48027,11371,0.87 [0.83-0.91],1.0374819268866615e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40340,1340,0.78 [0.68-0.89],0.0001746157553679
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40918,1918,0.86 [0.77-0.96],0.0091224846195569
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,40126,3470,0.80 [0.73-0.86],2.9488309969806616e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),43050,4050,0.89 [0.82-0.96],0.0018297732588396
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50330,199,0.58 [0.42-0.80],0.000933842577471
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37348,692,0.76 [0.64-0.91],0.0031892475390325
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37643,987,0.76 [0.66-0.89],0.0004933020001953
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48896,301,0.64 [0.49-0.83],0.0009037815582621
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39535,535,0.75 [0.61-0.92],0.0051001403423796
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48451,821,0.73 [0.62-0.86],0.0002120303493962
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47744,114,0.37 [0.25-0.54],4.355640575317473e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51974,655,0.78 [0.65-0.94],0.0079550832490806
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51952,633,0.76 [0.63-0.92],0.0054278590054102
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47402,11373,0.90 [0.86-0.94],9.39065327578014e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44550,8521,0.87 [0.83-0.92],2.591589270445848e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45740,897,0.75 [0.64-0.88],0.0003928519225049
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,44025,14638,0.90 [0.86-0.94],1.676372814349183e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,50205,5362,0.83 [0.78-0.89],4.130436378973113e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44725,269,0.63 [0.48-0.84],0.0014185576796534
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50790,142,0.59 [0.40-0.87],0.0072993651609422
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39438,3409,0.83 [0.76-0.90],5.622401601557652e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,46108,1265,0.76 [0.67-0.87],7.153658386219645e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51301,3441,0.84 [0.77-0.91],1.9990151494578665e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,50115,2255,0.81 [0.74-0.90],4.555414290958904e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51795,909,0.80 [0.68-0.94],0.0053777817081068
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,41044,5015,0.84 [0.79-0.90],5.3552934261611e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48624,764,0.77 [0.65-0.92],0.0030625055493747
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48477,3634,0.80 [0.74-0.87],5.2843459624980464e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46301,1458,0.74 [0.66-0.84],2.895361607387812e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40373,4344,0.91 [0.84-0.98],0.0086881174688086
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39300,3271,0.79 [0.72-0.85],1.5703141225632104e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,45164,321,0.67 [0.52-0.88],0.0031515203613062
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51819,883,0.78 [0.67-0.91],0.0020977668758997
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41231,1525,0.76 [0.67-0.86],7.95831761619556e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,41041,5012,0.86 [0.80-0.92],1.1484472000751969e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37347,1318,0.80 [0.70-0.91],0.0006444807293491
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36950,921,0.79 [0.67-0.92],0.0027502313200205
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45356,513,0.75 [0.60-0.92],0.0058026507374591
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40719,118,0.52 [0.34-0.79],0.002393140770161
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45939,1096,0.73 [0.63-0.84],1.158899329512351e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,49253,474,0.74 [0.59-0.92],0.0075054948264541
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47980,3137,0.79 [0.73-0.86],8.646824012949454e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46902,2059,0.81 [0.73-0.90],6.310949323957342e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49970,3172,0.89 [0.82-0.97],0.0055425373652185
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49875,3077,0.80 [0.74-0.87],5.281354738231143e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21942,1029,0.77 [0.67-0.89],0.0004670821137404
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43467,10815,0.88 [0.84-0.92],9.20234488064871e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49972,4568,0.88 [0.82-0.94],0.0003521280935435
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46850,1446,0.83 [0.73-0.94],0.0030262291646168
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48920,3516,0.86 [0.79-0.93],0.0002017983348955
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21071,158,0.62 [0.43-0.89],0.0096485343244381
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21022,109,0.55 [0.36-0.85],0.0071249851176996
FASLG,Tumor necrosis factor ligand superfamily member 6,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51577,5391,0.87 [0.82-0.93],2.660320680510256e-05
